335 related articles for article (PubMed ID: 33982652)
1. Artificial Intelligence and Cheminformatics-Guided Modern Privileged Scaffold Research.
Qiu HY; Clausen RP; He Y; Zhu HL
Curr Top Med Chem; 2021; 21(28):2593-2608. PubMed ID: 33982652
[TBL] [Abstract][Full Text] [Related]
2. Artificial intelligence and cheminformatics tools: a contribution to the drug development and chemical science.
Saifi I; Bhat BA; Hamdani SS; Bhat UY; Lobato-Tapia CA; Mir MA; Dar TUH; Ganie SA
J Biomol Struct Dyn; 2024 Aug; 42(12):6523-6541. PubMed ID: 37434311
[TBL] [Abstract][Full Text] [Related]
3. Highly Accurate Filters to Flag Frequent Hitters in AlphaScreen Assays by Suggesting their Mechanism.
Ghosh D; Koch U; Hadian K; Sattler M; Tetko IV
Mol Inform; 2022 Mar; 41(3):e2100151. PubMed ID: 34676998
[TBL] [Abstract][Full Text] [Related]
4. Artificial Intelligence and Machine Learning Technology Driven Modern Drug Discovery and Development.
Sarkar C; Das B; Rawat VS; Wahlang JB; Nongpiur A; Tiewsoh I; Lyngdoh NM; Das D; Bidarolli M; Sony HT
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768346
[TBL] [Abstract][Full Text] [Related]
5. From machine learning to deep learning: progress in machine intelligence for rational drug discovery.
Zhang L; Tan J; Han D; Zhu H
Drug Discov Today; 2017 Nov; 22(11):1680-1685. PubMed ID: 28881183
[TBL] [Abstract][Full Text] [Related]
6. Cheminformatics in Drug Discovery, an Industrial Perspective.
Chen H; Kogej T; Engkvist O
Mol Inform; 2018 Sep; 37(9-10):e1800041. PubMed ID: 29774657
[TBL] [Abstract][Full Text] [Related]
7. Evolving scenario of big data and Artificial Intelligence (AI) in drug discovery.
Tripathi MK; Nath A; Singh TP; Ethayathulla AS; Kaur P
Mol Divers; 2021 Aug; 25(3):1439-1460. PubMed ID: 34159484
[TBL] [Abstract][Full Text] [Related]
8. Machine Learning and Artificial Intelligence: A Paradigm Shift in Big Data-Driven Drug Design and Discovery.
Pasrija P; Jha P; Upadhyaya P; Khan MS; Chopra M
Curr Top Med Chem; 2022; 22(20):1692-1727. PubMed ID: 35786336
[TBL] [Abstract][Full Text] [Related]
9. Synergy between machine learning and natural products cheminformatics: Application to the lead discovery of anthraquinone derivatives.
Moshawih S; Goh HP; Kifli N; Idris AC; Yassin H; Kotra V; Goh KW; Liew KB; Ming LC
Chem Biol Drug Des; 2022 Aug; 100(2):185-217. PubMed ID: 35490393
[TBL] [Abstract][Full Text] [Related]
10. Recent trends in artificial intelligence-driven identification and development of anti-neurodegenerative therapeutic agents.
Kashyap K; Siddiqi MI
Mol Divers; 2021 Aug; 25(3):1517-1539. PubMed ID: 34282519
[TBL] [Abstract][Full Text] [Related]
11. Privileged scaffolds in lead generation.
Zhao H; Dietrich J
Expert Opin Drug Discov; 2015 Jul; 10(7):781-90. PubMed ID: 25959748
[TBL] [Abstract][Full Text] [Related]
12. New avenues in artificial-intelligence-assisted drug discovery.
Cerchia C; Lavecchia A
Drug Discov Today; 2023 Apr; 28(4):103516. PubMed ID: 36736583
[TBL] [Abstract][Full Text] [Related]
13. Concepts of Artificial Intelligence for Computer-Assisted Drug Discovery.
Yang X; Wang Y; Byrne R; Schneider G; Yang S
Chem Rev; 2019 Sep; 119(18):10520-10594. PubMed ID: 31294972
[TBL] [Abstract][Full Text] [Related]
14. Generative machine learning for de novo drug discovery: A systematic review.
Martinelli DD
Comput Biol Med; 2022 Jun; 145():105403. PubMed ID: 35339849
[TBL] [Abstract][Full Text] [Related]
15. Applications of artificial intelligence to drug design and discovery in the big data era: a comprehensive review.
Tripathi N; Goshisht MK; Sahu SK; Arora C
Mol Divers; 2021 Aug; 25(3):1643-1664. PubMed ID: 34110579
[TBL] [Abstract][Full Text] [Related]
16. Dealing with frequent hitters in drug discovery: a multidisciplinary view on the issue of filtering compounds on biological screenings.
Dantas RF; Evangelista TCS; Neves BJ; Senger MR; Andrade CH; Ferreira SB; Silva-Junior FP
Expert Opin Drug Discov; 2019 Dec; 14(12):1269-1282. PubMed ID: 31416369
[No Abstract] [Full Text] [Related]
17. Deep Learning in Drug Discovery.
Gawehn E; Hiss JA; Schneider G
Mol Inform; 2016 Jan; 35(1):3-14. PubMed ID: 27491648
[TBL] [Abstract][Full Text] [Related]
18. Artificial intelligence in drug discovery: recent advances and future perspectives.
Jiménez-Luna J; Grisoni F; Weskamp N; Schneider G
Expert Opin Drug Discov; 2021 Sep; 16(9):949-959. PubMed ID: 33779453
[No Abstract] [Full Text] [Related]
19. Machine learning and AI-based approaches for bioactive ligand discovery and GPCR-ligand recognition.
Raschka S; Kaufman B
Methods; 2020 Aug; 180():89-110. PubMed ID: 32645448
[TBL] [Abstract][Full Text] [Related]
20. Structure-Based Drug Discovery with Deep Learning.
Özçelik R; van Tilborg D; Jiménez-Luna J; Grisoni F
Chembiochem; 2023 Jul; 24(13):e202200776. PubMed ID: 37014633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
